Related content

Glycoprotein IIb/IIIa Blockers in Non-ST Elevation Acute Coronary Syndromes: Only for Well Defined Subgroups or a Therapeutic Option for All Patients?

By Verheugt Freek W.A.  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite

Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes

By Ray Kausik   Nazer Babak   Cairns Richard   Michael Gibson C.   Cannon Christopher  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 1, 2010-07 ,pp. : 10-13

Springer Publishing Company

Access to resources Recommend Favorite

Paradoxical coronary embolism causing non-ST segment elevation myocardial infarction in a case of pulmonary embolism

By Haghi D.  

Zeitschrift für Kardiologie, Vol. 93, Iss. 10, 2004-10 ,pp. : 824-828

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

By Saucedo Jorge F.   Lui Henry K.   Garza Luis   Guerra G. Jose   Jacoski Mary V.   Jennings Lisa K.  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 2, 2004-10 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes

By White H.D.   French J.K.  

Journal of the American College of Cardiology, Vol. 42, Iss. 11, 2003-12 ,pp. : 1917-1920

Elsevier

Access to resources Recommend Favorite